Metropolis Healthcare
BSE: 542650 | NSE: METROPOLIS | ISIN: INE112L01020 | SECTOR: Healthcare FacilitiesOpen
1,784.65High
1,820.00Low
1,774.30Prev Close
1,768.55P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
92.72BVolume
4.06KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
1,809.35Ask
1,812.35
Promoter Pledge Holding - 0.59%
| Promoter Name | No of Shares | Percentage |
|---|---|---|
| Metz Advisory Llp | 3,00,000 | 0.58% |
Company Description
- Healthcare Facilities
BSE
542650NSE
METROPOLISISIN
INE112L01020
Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.
Company Officers
Sushil Shah
Executive Chairman of the BoardNilesh Shah
Group President, Chief - Science and InnovationSurendran Chemmenkottil
Chief Executive OfficerRakesh Agarwal
Chief Financial OfficerIshita Medhekar
Chief Human Resource OfficerKirti Chadha
Chief Scientific Officer, Group CSR HeadKamlesh Kulkarni
Compliance Officer, Company SecretaryAmeera Shah
Managing Director, Executive DirectorKannan Alangadan
Chief Operating Officer - OperationsSriram Iyer
Chief Revenue Officer